Callie is a Vice President at ICR Westwicke, joining the Medical Technology and Diagnostics team in June 2021. Her daily responsibilities include preparing investor relations materials, including press releases, corporate presentations, and company descriptive materials. Additionally, Callie supports her clients with capital markets engagements, assisting with the preparation for, and execution of, Initial Public Offerings (IPOs), Special Purpose Acquisition Company (SPAC) business combinations, and private financings.
Prior to joining ICR Westwicke, Callie worked as a Deal Analyst at EquityZen, a marketplace for Pre-IPO companies. At EquityZen, she managed internal operations for various growth technology funds, as well as external communications with investors and shareholders. She graduated from Boston College in December of 2018 and is based out of New York City.